Point72 Asset Management, L.P. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2023$33,990
-99.1%
11,000
-97.3%
0.00%
-100.0%
Q4 2019$3,605,000
-33.8%
411,978
-18.6%
0.02%
-42.4%
Q3 2019$5,449,000
+79.2%
506,221
+111.7%
0.03%
+106.2%
Q2 2019$3,040,000
+5529.6%
239,173
+16983.8%
0.02%
Q1 2019$54,000
-98.3%
1,400
-99.1%
0.00%
-100.0%
Q4 2018$3,117,000
-91.1%
153,158
-80.0%
0.02%
-89.7%
Q3 2018$35,056,000
-35.6%
764,590
-16.9%
0.14%
-33.2%
Q2 2018$54,405,000
-37.6%
919,775
-28.2%
0.22%
-40.4%
Q1 2018$87,180,000
+238.1%
1,281,117
+391.1%
0.36%
+227.9%
Q4 2017$25,785,000
-55.3%
260,852
-45.9%
0.11%
-57.0%
Q3 2017$57,743,000
+400.9%
482,200
+265.6%
0.26%
+296.9%
Q2 2017$11,528,000
-83.3%
131,900
-87.2%
0.06%
-86.6%
Q3 2016$68,975,000
+63.5%
1,028,706
-27.3%
0.48%
+69.0%
Q2 2016$42,177,000
+24.0%
1,415,800
+22.3%
0.29%
+10.0%
Q1 2016$34,002,000
-54.1%
1,157,700
+22.4%
0.26%
-57.3%
Q4 2015$74,125,000
+77.5%
945,478
+70.7%
0.61%
+86.3%
Q3 2015$41,751,000
+421.3%
554,019
+707.6%
0.33%
+496.4%
Q2 2015$8,009,000
+272.7%
68,600
+653.8%
0.06%
+266.7%
Q1 2015$2,149,000
-90.1%
9,100
-97.2%
0.02%
-89.2%
Q2 2014$21,641,000327,9000.14%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders